Likely Diagnosis and Management
The most likely diagnosis is endometriosis with gastrointestinal involvement, and you should initiate empiric medical therapy with oral contraceptives or progestins while arranging diagnostic imaging and gynecology referral.
Diagnostic Reasoning
The presentation of severe epigastric pain occurring cyclically during menstruation in a young woman is highly suggestive of endometriosis affecting the gastrointestinal tract. While typical endometriosis presents with pelvic pain, dysmenorrhea, or dyspareunia, bowel endometriosis can manifest as epigastric or abdominal pain that is strictly menstrual in timing 1. This unusual presentation has been documented, with one case specifically describing epigastric pain during menses as the presenting symptom of ileocecal endometriosis 1.
The key diagnostic feature here is the temporal relationship to menstruation—pain that occurs specifically during menses over a 2-year period strongly points toward hormonally-responsive tissue. Under hormonal influences, ectopic endometrial tissue proliferates and bleeds within the bowel wall, causing cyclical abdominal pain 2.
Diagnostic Workup
Order transvaginal ultrasound and consider pelvic MRI to evaluate for endometriotic lesions, particularly those involving the bowel. The case literature demonstrates that imaging can identify lesions at the ileocecal junction and other gastrointestinal sites 1.
Upper endoscopy is typically normal in bowel endometriosis since the disease affects the serosal and muscular layers rather than the mucosa 1. However, it may be reasonable to perform if you need to exclude peptic disease, though the menstrual timing makes this less likely.
Important caveat: Histologic confirmation is the gold standard for diagnosis 3, but ACOG guidelines support empiric medical therapy for chronic pelvic pain even without surgical confirmation, provided other causes have been excluded 3.
Medical Management (First-Line)
Start with oral contraceptives or depot medroxyprogesterone acetate immediately 3. These are:
- Effective compared to placebo for pain relief
- Equivalent to more costly regimens
- Based on Level B evidence from ACOG guidelines
- Safe and appropriate as first-line therapy
Alternative first-line options include:
Second-Line Medical Options
If first-line therapy fails after 3-6 months:
GnRH agonists for at least 3 months are equally effective to danazol (6 months) for pain relief, with Level A evidence 3. When using GnRH agonists:
- Always add add-back therapy (estrogen/progestin) to prevent bone mineral loss without reducing pain relief efficacy 3
- This is supported by Level A evidence
Surgical Considerations
Reserve surgery for patients who fail medical management or have severe disease. Key points:
- Surgery provides significant pain reduction in the first 6 months 3
- 44% experience symptom recurrence within one year 3
- For severe endometriosis, medical treatment alone may be insufficient 3
- If bowel involvement is confirmed on imaging, laparoscopic resection with bowel anastomosis may be necessary 1
Critical Pitfalls to Avoid
Don't dismiss epigastric pain as purely gastrointestinal in reproductive-aged women—always assess the relationship to menstruation 1, 2
Don't delay treatment waiting for laparoscopic confirmation—ACOG supports empiric therapy when detailed evaluation excludes other causes 3
Don't use GnRH agonists without add-back therapy—this causes unnecessary bone loss 3
Don't assume normal upper endoscopy rules out bowel endometriosis—the disease affects deeper layers 1
Algorithmic Approach
- Confirm menstrual timing of pain over multiple cycles
- Exclude other causes: Order basic labs, consider upper endoscopy if atypical features present
- Start oral contraceptives or progestins immediately
- Order transvaginal ultrasound ± pelvic MRI to assess extent of disease
- Refer to gynecology for co-management
- If inadequate response at 3-6 months: Switch to GnRH agonist with add-back therapy
- If medical therapy fails: Consider surgical evaluation, especially if imaging shows bowel involvement
The menstrual timing of symptoms over 2 years makes endometriosis the overwhelming diagnostic consideration, and the evidence strongly supports initiating medical therapy without delay while completing the diagnostic workup.